InvestorsHub Logo
icon url

Pontoon

03/14/13 2:41 PM

#26722 RE: mantis #26721

Mantis, Really, the money thing..what ARE we here for? As a business owner myself, I realize that investors want to be kept up to date on what is going to move a stock - and when. In KarinCA's latest interview, Leo went through the status of both flagship drugs Kavetrin and Prurisol, plus indicating that he is cognizant of maximizing shareholder value and etc. To me that's a good mix.
As for your cash position,if you are NOT a risk taker, keep the cash. If you want to maximize the (probable) ride of a lifetime, go whole-hog. I have. Getting in under two bucks is peanuts.



mantis Member Profile mantis

Thursday, March 14, 2013 2:24:54 PM
Re: None
Post # of 26721
Found this 2+ years old article ( see below). Anyone here remembers those times ? Care to elaborate on what happened ? Was the company really in such a bad shape back then ?
The current CEO talks about money too much for my liking. I have 10k shares, have more cash ready , but not sure if I want to get more.
icon url

BonelessCat

03/14/13 2:51 PM

#26723 RE: mantis #26721

The difference between then and now: Evans demanded that his compensation come out of research grants, even before his resignation, which would have gutted the grant money. Leo Ehrlich, the acting CEO then and now CEO, loaned the company $2 million out of his own pocket to further fund research and development.

Two very different CEOs, where one very nearly put his own company out of business (how was he performing his duties if there was only $5K in the bank when he "resigned"?), the other took the company from pre-clinical to clinical stage with a healthy treasury and line of credit from which to draw.
icon url

situps00

03/15/13 9:29 AM

#26822 RE: mantis #26721

Things that make you go "hmmmmmmmmm"